基于生理的药代动力学模型的生理参数值。 - Suppr

Suppr

超能文献

Physiological parameter values for physiologically based pharmacokinetic models.

作者信息

Brown R P, Delp M D, Lindstedt S L, Rhomberg L R, Beliles R P

机构信息

Risk Science Institute, International Life Sciences Institute Washington, DC, USA.

出版信息

Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84. doi: 10.1177/074823379701300401.

DOI:10.1177/074823379701300401

PMID:9249929

Abstract

摘要

相似文献

Physiological parameter values for physiologically based pharmacokinetic models.

Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84. doi: 10.1177/074823379701300401.

Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.

J Biopharm Stat. 1995 Nov;5(3):245-71.

Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling.

J Pharmacol Toxicol Methods. 2008 Nov-Dec;58(3):198-205. doi: 10.1016/j.vascn.2008.08.001. Epub 2008 Aug 13.

A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan.

Regul Toxicol Pharmacol. 2010 Jun;57(1):103-16. doi: 10.1016/j.yrtph.2010.01.005. Epub 2010 Feb 1.

An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry.

Crit Rev Toxicol. 2012 Oct;42(9):751-67. doi: 10.3109/10408444.2012.709225. Epub 2012 Sep 7.

Organ growth functions in maturing male Sprague-Dawley rats.

J Toxicol Environ Health A. 2007 Mar 1;70(5):429-38. doi: 10.1080/15287390600755265.

A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat.

Toxicol Appl Pharmacol. 1998 Jun;150(2):205-17. doi: 10.1006/taap.1998.8405.

Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.

Environ Res. 1994 Oct;67(1):54-67. doi: 10.1006/enrs.1994.1064.

Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.

Clin Pharmacokinet. 2019 Feb;58(2):235-262. doi: 10.1007/s40262-018-0685-y.

Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.

Regul Toxicol Pharmacol. 2015 Nov;73(2):530-43. doi: 10.1016/j.yrtph.2015.07.012. Epub 2015 Jul 16.

引用本文的文献

A Parent-Metabolite Middle-Out PBPK Model for Genistein and Its Glucuronide Metabolite in Rats: Integrating Liver and Enteric Metabolism with Hepatobiliary and Enteroluminal Transport to Assess Glucuronide Recycling.

Pharmaceutics. 2025 Jun 23;17(7):814. doi: 10.3390/pharmaceutics17070814.

Physiologically-based pharmacokinetic model for predicting drug-drug interactions perpetrated by posaconazole in healthy subjects with normal weight and obesity: Concomitant use and washout.

J Pharmacokinet Pharmacodyn. 2025 Jul 18;52(4):39. doi: 10.1007/s10928-025-09983-6.

Predicting the developmental toxicity of 8-methyl-benzo[a]pyrene (BaP) by physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry and read-across from BaP.

Arch Toxicol. 2025 Jul 3. doi: 10.1007/s00204-025-04115-y.

Systemic metabolic changes in acute and chronic lymphocytic choriomeningitis virus infection.

Mol Metab. 2025 Jun 26;99:102194. doi: 10.1016/j.molmet.2025.102194.

A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide.

AAPS J. 2025 Jun 2;27(4):101. doi: 10.1208/s12248-025-01061-6.

Estimation of Dermal Exposure to Volatile Organic Compounds (VOCs) from Feminine Hygiene Products: Integrating Measurement Data and Physiologically Based Toxicokinetic (PBTK) Model.

Environ Health Perspect. 2025 Jun;133(6):67020. doi: 10.1289/EHP15418. Epub 2025 Jun 20.

Determining an appropriate fosfomycin (ZTI-01) dosing regimen in pneumonia patients by utilizing minimal PBPK modeling and target attainment analysis.

Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0186924. doi: 10.1128/aac.01869-24. Epub 2025 May 5.

Specific quantification of intact lipid nanocapsules in rats using FRET: biodistribution and PBPK model development.

Nanomedicine (Lond). 2025 May;20(10):1101-1112. doi: 10.1080/17435889.2025.2492537. Epub 2025 Apr 24.

Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans.

Sci Rep. 2025 Apr 21;15(1):13721. doi: 10.1038/s41598-025-98202-w.

Extension and validation of a physiologically based toxicokinetic model for risk assessment of aluminium exposure in humans.

Arch Toxicol. 2025 Jun;99(6):2379-2395. doi: 10.1007/s00204-025-04031-1. Epub 2025 Apr 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验